ERA-NET PathoGenoMics M. Karrasch, FZJ 27.09.2005 5th Executing Board Meeting 27th September,...

25
ERA-NET PathoGenoMics M. Karrasch, FZJ 27.09.2005 5th Executing Board Meeting 27th September, Helsinki Dr. Marion Karrasch-Bott ERA-NET PathoGenoMics - Joint Secretariat

Transcript of ERA-NET PathoGenoMics M. Karrasch, FZJ 27.09.2005 5th Executing Board Meeting 27th September,...

Page 1: ERA-NET PathoGenoMics M. Karrasch, FZJ 27.09.2005 5th Executing Board Meeting 27th September, Helsinki Dr. Marion Karrasch-Bott ERA-NET PathoGenoMics.

ERA-NET PathoGenoMics

M. Karrasch, FZJ27.09.2005

5th Executing Board Meeting

27th September, Helsinki

Dr. Marion Karrasch-Bott

ERA-NET PathoGenoMics - Joint Secretariat

Page 2: ERA-NET PathoGenoMics M. Karrasch, FZJ 27.09.2005 5th Executing Board Meeting 27th September, Helsinki Dr. Marion Karrasch-Bott ERA-NET PathoGenoMics.

ERA-NET PathoGenoMics

M. Karrasch, FZJ27.09.2005

1. Meetings / Reporting

2. Financial status

3. Deliverables and Milestones

4. WP 5: preparation of the partnering event

WP 6: Training and mobility

WP 9: Science and Society

Page 3: ERA-NET PathoGenoMics M. Karrasch, FZJ 27.09.2005 5th Executing Board Meeting 27th September, Helsinki Dr. Marion Karrasch-Bott ERA-NET PathoGenoMics.

ERA-NET PathoGenoMics

M. Karrasch, FZJ27.09.2005

Deliv.No

Deliverable name

Due date

Current status Comple-tion

Submission to EC

D 10.3 Consortium management reporting(progress and financial reports, audit certificates)

MM 12, 24, 36, 48, 60

Consortium management reporting

Financial report and audit certificates due in MM 18, 36 and 60

MM 2

MM 7

MM 12

MM 3(15th Nov 2004)MM 7(1st Mar 2005)MM 12(16th Aug 2005)

D 10.5 NSC and EB meetings incl. quarterly circulars

MM 1, 3, 6, 9, 12, ..., 60

The 1st NSC meeting and the 1st EB meeting: 13th – 15th October 2004 in Berlin

The 2nd EB meeting: 20th January in Bonn, Germany

The 3rd EB/ 2nd NSC meeting: 7th/8th of April in Bonn, Germany

The 4th EB meeting: 27th/28th of June in Vienna, Austria

The 5th EB/ 3rd NSC meeting: 26th/27th of September in Helsinki, Finland

MM 2

MM 5

MM 8

MM 10

MM 3(15th Nov 2004)

MM 7(1st Mar 2005)

MM 12(16th Aug 2005)

MM 12(16th Aug 2005)

All interim reports are available on the internal web pages -> „Finance-tool“ -> „Goto texts section“

Either: -> „view all tasks“ -> list of all stored texts, including the interim reports

Or: choose the respective month -> „November 2004“ -> Interim report 11/2004„March 2005“ -> Interim report 03/2005„August 2005“ -> Interim report 08/2005

All meeting minutes are available on the internal web pages -> „Meetings“

Page 4: ERA-NET PathoGenoMics M. Karrasch, FZJ 27.09.2005 5th Executing Board Meeting 27th September, Helsinki Dr. Marion Karrasch-Bott ERA-NET PathoGenoMics.

ERA-NET PathoGenoMics

M. Karrasch, FZJ27.09.2005

Meeting no. Date place Minutes taker

NSC 1 / EB 1 10/04 Berlin Karrasch

EB 2 01/05 Bonn Glaser/Karrasch

NSC 2 / EB 3 04/05 Bonn Joint secretariat

EB 4 06/05 Vienna Firnberg

NSC 3 / EB 5 09/05 Helsinki Joint secretariat

EB 6 12/05 (Barcelona) Juuti

NSC 4 / EB 7 03-04/06 (Jerusalem) Joint secretariat

EB 8 (06/06) n.d. Allon

NSC 5 / EB 9 (09/06) n.d. Joint secretariat

EB 10 (12/06) n.d. Salas/Barbas

NSC 6 / EB 11 n.d. Joint secretariat

Meetings

Page 5: ERA-NET PathoGenoMics M. Karrasch, FZJ 27.09.2005 5th Executing Board Meeting 27th September, Helsinki Dr. Marion Karrasch-Bott ERA-NET PathoGenoMics.

ERA-NET PathoGenoMics

M. Karrasch, FZJ27.09.2005

1. Meetings

2. Financial status

3. Deliverables and Milestones

4. WP 5: preparation of the partnering event

WP 6: Training and mobility

WP 9: Science and Society

Page 6: ERA-NET PathoGenoMics M. Karrasch, FZJ 27.09.2005 5th Executing Board Meeting 27th September, Helsinki Dr. Marion Karrasch-Bott ERA-NET PathoGenoMics.

ERA-NET PathoGenoMics

M. Karrasch, FZJ27.09.2005

Reminder:

- Please enter all your costs into our Finance tool

- Please enter your costs according to the Workpackages/Tasks (WP 1-9)

- WP 10 (Consortium management): here you enter only your audit costs (nothing else!)

Page 7: ERA-NET PathoGenoMics M. Karrasch, FZJ 27.09.2005 5th Executing Board Meeting 27th September, Helsinki Dr. Marion Karrasch-Bott ERA-NET PathoGenoMics.

ERA-NET PathoGenoMics

M. Karrasch, FZJ27.09.2005

• enter your expenses in our Finance Tool as often as necessary (at least monthly)forgot your passwords: please contact us

• Record your personnel working hours e.g. via the report Form(was provided by us and may be provided again if necessary)

• Provide the Task Leaders / Work Package Leaders with the relevant information necessary for fulfilling the task

Reporting: what do you have to do?

WP 10 („Consortium Management“):Here you enter ONLY YOUR AUDIT COSTS!!!

Page 8: ERA-NET PathoGenoMics M. Karrasch, FZJ 27.09.2005 5th Executing Board Meeting 27th September, Helsinki Dr. Marion Karrasch-Bott ERA-NET PathoGenoMics.

ERA-NET PathoGenoMics

M. Karrasch, FZJ27.09.2005

Financial Audit after 18 months: 28th February 2006

Deadline for delivery of the audit certificate to the coordinator: 24th March 2006

Latest date for delivery to the KOM: 45 days after end of reporting peroid: 14th April 2006 Contact your auditor early enough to be prepared

for delivering your certificate IN TIME

Page 9: ERA-NET PathoGenoMics M. Karrasch, FZJ 27.09.2005 5th Executing Board Meeting 27th September, Helsinki Dr. Marion Karrasch-Bott ERA-NET PathoGenoMics.

ERA-NET PathoGenoMics

M. Karrasch, FZJ27.09.2005

Partner DE AT FI FR HU IL LV PT SV ES Sum

P1 P3 P4 P5 P11/12 P7 P8 P9 P10 P11

1st payment: 80% pre-financing 1st

period

415231 88608 172965 143760 67303 130142 70288 70288 70288 84150 1313023 payment after project start (except HU)

2nd payment: final 20% 1st period +

80% pre-financing 2nd period

220927 77288 88533 113397 51942 88388 49331 49331 49331 106364 894833 payment after submission of 1st audit certificate

3rd payment: final 20% 2nd period +

80% pre-financing 3rd period

149821 109500 37787 82758 35663 75262 30772 30772 30772 76525 659633 payment after submission of 2nd audit certificate

4th payment: final 20% 3rd period

30331 24304 6616 15786 2876 15152 5708 5708 5708 18521 130711 payment after submission of 3rd audit certificate

TOTAL added 816311 299700 305900 355701 157784 308944 156100 156100 156100 285560 2998200TOTAL

precalculated812298 269700 266900 385700 252700 311700 156100 156100 156100 232700 3000000

difference due to reallocations

4013 30000 39000 -30000 -94916 -2757 0 0 0 52860 -1800

Partner DE AT FI FR HU IL LV PT SV ES Sum

√ √ √ √ √ √ √ √ √

Payment schedule

Page 10: ERA-NET PathoGenoMics M. Karrasch, FZJ 27.09.2005 5th Executing Board Meeting 27th September, Helsinki Dr. Marion Karrasch-Bott ERA-NET PathoGenoMics.

ERA-NET PathoGenoMics

M. Karrasch, FZJ27.09.2005

4 8 12 16 20 24

100.000

Budget;costs (€)

200.000AT

IL

months0

DE

LV

CostsPrecalculated

budget

Overview month 1-24:precalculated versus actual costs

ES

FI

Page 11: ERA-NET PathoGenoMics M. Karrasch, FZJ 27.09.2005 5th Executing Board Meeting 27th September, Helsinki Dr. Marion Karrasch-Bott ERA-NET PathoGenoMics.

ERA-NET PathoGenoMics

M. Karrasch, FZJ27.09.2005

12 24 36 48 60

800.000

Budget;costs (€) DE

400.000

months0

Without Foresight study

PlusForesight study

Overview month 1-60:precalculated versus actual costs

Page 12: ERA-NET PathoGenoMics M. Karrasch, FZJ 27.09.2005 5th Executing Board Meeting 27th September, Helsinki Dr. Marion Karrasch-Bott ERA-NET PathoGenoMics.

ERA-NET PathoGenoMics

M. Karrasch, FZJ27.09.2005 12 24 36 48 60

200.000

Budget;costs (€)

300.000

100.000

AT

IL

months0

LV

Overview month 1-60:precalculated versus actual costs

ES

FI

Page 13: ERA-NET PathoGenoMics M. Karrasch, FZJ 27.09.2005 5th Executing Board Meeting 27th September, Helsinki Dr. Marion Karrasch-Bott ERA-NET PathoGenoMics.

ERA-NET PathoGenoMics

M. Karrasch, FZJ27.09.2005 12 24 36 48 60

2.000.000

Budget and costs (€)

3.000.000

1.000.000

months0

Estimatedbased on the costs

of AT, FI, DE, IL, LV and ES

Page 14: ERA-NET PathoGenoMics M. Karrasch, FZJ 27.09.2005 5th Executing Board Meeting 27th September, Helsinki Dr. Marion Karrasch-Bott ERA-NET PathoGenoMics.

ERA-NET PathoGenoMics

M. Karrasch, FZJ27.09.2005

1. Meetings

2. Financial status

3. Deliverables and Milestones

4. WP 5: preparation of the partnering event

WP 6: Training and mobility

WP 9: Science and Society

Page 15: ERA-NET PathoGenoMics M. Karrasch, FZJ 27.09.2005 5th Executing Board Meeting 27th September, Helsinki Dr. Marion Karrasch-Bott ERA-NET PathoGenoMics.

ERA-NET PathoGenoMics

M. Karrasch, FZJ27.09.2005

Month 24 604812 36

0 24 604812 36

Timetable Deliverables: due dates

D 1.1 D 1.2 D 1.3D 2.1, 2.2, 2.3

D 3.1

D 4.1

D 5.1D 6.1

D 6.2

D 7.1, 7.2, 7.3

D 8.1

D 9.1, 9.2

D 10.1, 10.2

D 2.4

D 3.2

D 3.3D 3.3

D 4.2, 4.3

D 5.2

D 7.4D 8.1

D 8.2 D 8.2

D 8.3, 8.4D 8.3 D 8.4D 8.4

D 9.2 D 9.2 D 9.2 D 9.2 D 9.2

D 10.4D 10.3 D 10.3 D 10.3

D 10.5

Page 16: ERA-NET PathoGenoMics M. Karrasch, FZJ 27.09.2005 5th Executing Board Meeting 27th September, Helsinki Dr. Marion Karrasch-Bott ERA-NET PathoGenoMics.

ERA-NET PathoGenoMics

M. Karrasch, FZJ27.09.2005

Month 24 604812 36

0 24 604812 36

D 1.1

Timetable Deliverables: completion dates

D 1.2 D 1.3D 2.1, 2.2, 2.3

D 3.1

D 6.1D 6.2

D 7.1, 7.2, 7.3

D 8.1

D 9.1, 9.2

D 10.1, 10.2

D 2.4

D 3.2

D 3.3

D 5.2

D 7.4D 8.1

D 8.2 D 8.2

D 8.3, 8.4D 8.3 D 8.4D 8.4

D 9.3 D 9.3 D 9.3 D 9.3

D 10.4D 10.3 D 10.3 D 10.3

D 10.5

D 4.1

D 4.2, 4.3

D 5.1

D 3.3

D 9.3

Page 17: ERA-NET PathoGenoMics M. Karrasch, FZJ 27.09.2005 5th Executing Board Meeting 27th September, Helsinki Dr. Marion Karrasch-Bott ERA-NET PathoGenoMics.

ERA-NET PathoGenoMics

M. Karrasch, FZJ27.09.2005

1. Meetings

2. Financial status

3. Deliverables and Milestones

4. WP 5: preparation of the partnering event

WP 6: Training and mobility

WP 9: Science and Society

Page 18: ERA-NET PathoGenoMics M. Karrasch, FZJ 27.09.2005 5th Executing Board Meeting 27th September, Helsinki Dr. Marion Karrasch-Bott ERA-NET PathoGenoMics.

ERA-NET PathoGenoMics

M. Karrasch, FZJ27.09.2005

Page 19: ERA-NET PathoGenoMics M. Karrasch, FZJ 27.09.2005 5th Executing Board Meeting 27th September, Helsinki Dr. Marion Karrasch-Bott ERA-NET PathoGenoMics.

ERA-NET PathoGenoMics

M. Karrasch, FZJ27.09.2005

Suggestions for the 6th EB meeting:

Date: Friday, 2nd December 2005 (arrival on the 1st December)

Place: Barcelona

Potential topics:

- Project management of the first joint calle.g. amendments / changes to the call addenda

- Preparation of the WP 4 activities (PIP network etc.)

- Finalization of WP 3 (Strategic Research Agenda)

- Preparation of the Israel meeting (NSC 4, EB 7)

back

Page 20: ERA-NET PathoGenoMics M. Karrasch, FZJ 27.09.2005 5th Executing Board Meeting 27th September, Helsinki Dr. Marion Karrasch-Bott ERA-NET PathoGenoMics.

ERA-NET PathoGenoMics

M. Karrasch, FZJ27.09.2005

Suggestions for the 4th NSC / 7th EB meeting:

Date: Monday, 3rd April 2006 – Tuesday, 4th April 2006(arrival on the 2nd April)

Place: Jerusalem

Potential topics:

- first discussion of the received proposals from the first joint call

- preparation of the evaluation session

- preparation of the second joint call

back

Page 21: ERA-NET PathoGenoMics M. Karrasch, FZJ 27.09.2005 5th Executing Board Meeting 27th September, Helsinki Dr. Marion Karrasch-Bott ERA-NET PathoGenoMics.

ERA-NET PathoGenoMics

M. Karrasch, FZJ27.09.2005

Month 24 604812 36

0 24 604812 36

D 1.1

Timetable Deliverables: completion dates

D 1.2 D 1.3D 2.1, 2.2, 2.3

D 3.1

D 6.1D 6.2

D 7.1, 7.2, 7.3

D 8.1

D 9.1, 9.2

D 10.1, 10.2

D 2.4

D 3.2

D 3.3

D 5.2

D 7.4D 8.1

D 8.2 D 8.2

D 8.3, 8.4D 8.3 D 8.4D 8.4

D 9.3 D 9.3 D 9.3 D 9.3

D 10.4D 10.3 D 10.3 D 10.3

D 10.5

D 4.1

D 4.2, 4.3

D 5.1

D 3.3

back

D 3.2: Minutes from expert workshop 1 per session (Paris, May 05) Due date: Completion date: MM 13

D 3.3: European Research Agenda 1. published draft 2. final version Due dates: 1. 2. MM 15 Approx. Completion dates: 1. MM 13 ? 2. MM 17 ?

MM 9

MM 11

D 9.3

Page 22: ERA-NET PathoGenoMics M. Karrasch, FZJ 27.09.2005 5th Executing Board Meeting 27th September, Helsinki Dr. Marion Karrasch-Bott ERA-NET PathoGenoMics.

ERA-NET PathoGenoMics

M. Karrasch, FZJ27.09.2005

Month 24 604812 36

0 24 604812 36

D 1.1

Timetable Deliverables: completion dates

D 1.2 D 1.3D 2.1, 2.2, 2.3

D 3.1

D 6.1D 6.2

D 7.1, 7.2, 7.3

D 8.1

D 9.1, 9.2

D 10.1, 10.2

D 2.4

D 3.2

D 3.3

D 5.2

D 7.4D 8.1

D 8.2 D 8.2

D 8.3, 8.4D 8.3 D 8.4D 8.4

D 9.3 D 9.3 D 9.3 D 9.3 D 9.3

D 10.4D 10.3 D 10.3 D 10.3

D 10.5

D 5.1

D 3.3

Deliv.No

Deliverable name Due date (DoW)

Current status

Approx. Comple-tion

D 4.1 Strategy paper “Innovation potentials & perspectives in pathogenomics”

MM 13 1st presentation planned in MM 13

MM 17

D 4.2 Supporting network of innovation partners (PIPs) incl.minutes of 5 annual meetings (MM 15, 24, 36, 48, 60)

MM 15 1st PIP meeting planned for MM 17

MM 17

D 4.3 Web-based innovation market(including multiplication system)

MM 15 Will be delayed due to delay in D 4.1 and 4.2

D 4.1

D 4.2, 4.3

WP 4: Stimulating the environment for a wider exploitation and job

creation

back

Page 23: ERA-NET PathoGenoMics M. Karrasch, FZJ 27.09.2005 5th Executing Board Meeting 27th September, Helsinki Dr. Marion Karrasch-Bott ERA-NET PathoGenoMics.

ERA-NET PathoGenoMics

M. Karrasch, FZJ27.09.2005

Month 24 604812 36

0 24 604812 36

D 1.1

Timetable Deliverables: completion dates

D 1.2 D 1.3D 2.1, 2.2, 2.3

D 3.1

D 6.1D 6.2

D 7.1, 7.2, 7.3

D 8.1

D 9.1, 9.2

D 10.1, 10.2

D 2.4

D 3.2

D 3.3

D 5.2

D 7.4D 8.1

D 8.2 D 8.2

D 8.3, 8.4D 8.3 D 8.4D 8.4

D 9.3 D 9.3 D 9.3 D 9.3

D 10.4D 10.3 D 10.3 D 10.3

D 10.5

D 4.1

D 4.2, 4.3

D 5.1

D 3.3

D 5.1: Partnering workshop in HelsinkiDue date: MM 13

current status:Planned for Feb. 06in collaboration with NoE “EuroPathogenomics”;approx. 2 months after call publication;probably not in Helsinki

D 9.3

back

Page 24: ERA-NET PathoGenoMics M. Karrasch, FZJ 27.09.2005 5th Executing Board Meeting 27th September, Helsinki Dr. Marion Karrasch-Bott ERA-NET PathoGenoMics.

ERA-NET PathoGenoMics

M. Karrasch, FZJ27.09.2005

Month 24 604812 36

0 24 604812 36

D 1.1

Timetable Deliverables: completion dates

D 1.2 D 1.3D 2.1, 2.2, 2.3

D 3.1

D 6.1D 6.2

D 7.1, 7.2, 7.3

D 8.1

D 9.1, 9.2

D 10.1, 10.2

D 2.4

D 3.2

D 3.3

D 5.2

D 7.4D 8.1

D 8.2 D 8.2

D 8.3, 8.4D 8.3 D 8.4D 8.4

D 9.3 D 9.3 D 9.3 D 9.3 D 9.3

D 10.4D 10.3 D 10.3 D 10.3

D 10.5

D 4.1

D 4.2, 4.3

D 5.1

D 3.3

D 9.1: IT-based communication and information platform(with media service, archive, event calendars, etc.)Due date: MM 9current status:PathoGenoMics web pages publicly accessible since10th of October 2004. Communication and information platform is being programmed at the moment;will presumably be available in September 2005

D 9.2: Printed information material(e.g. teaching aids, annual reports, brochures, leaflets)Due date: MM 9Current status:First brochure about the PathoGenoMics ERA-NET is available in August 2005

back

Page 25: ERA-NET PathoGenoMics M. Karrasch, FZJ 27.09.2005 5th Executing Board Meeting 27th September, Helsinki Dr. Marion Karrasch-Bott ERA-NET PathoGenoMics.

ERA-NET PathoGenoMics

M. Karrasch, FZJ27.09.2005

Month 24 604812 36

0 24 604812 36

D 1.1

Timetable Deliverables: completion dates

D 1.2 D 1.3D 2.1, 2.2, 2.3

D 3.1

D 6.1D 6.2

D 7.1, 7.2, 7.3

D 8.1

D 9.1, 9.2

D 10.1, 10.2

D 2.4

D 3.2

D 3.3

D 5.2

D 7.4D 8.1

D 8.2 D 8.2

D 8.3, 8.4D 8.3 D 8.4D 8.4

D 9.3 D 9.3 D 9.3 D 9.3

D 10.4D 10.3 D 10.3 D 10.3

D 10.5

D 4.1

D 4.2, 4.3

D 5.1

D 3.3

D 9.3

D 9.3: On-spot presentations(annually, at special events)Due dates: MM 10, 19, 32, 43, 55)

Completion dates: ?

back